Altimmune's total assets for Q4 2024 were $139.31M, a decrease of -5.79% from the previous quarter. GB:0A4C total liabilities were $15.80M for the fiscal quarter, a 9.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.